With your support and other donors, APFED can continue its mission of improving the lives of those living with eosinophilic disorders.
Donate Today Gift StoreFunded study will examine the role of QSOX1 in the pathogenesis of eosinophil-related diseases ATLANTA,...
Find Out MoreIn a publication in the October 22, 2020 issue of New England Journal of Medicine,...
Find Out MoreThe annual scientific meeting of the American College of Gastroenterology took place online, Oct. 23-28,...
Find Out MoreFor Immediate Release APFED Contact: Mary Jo Strobel, Executive Director, (713) 493-7749, mjstrobel@apfed.org APFED’s Virtual...
Find Out MoreThere is a founding principle within APFED: “We Get It!” And we do. Our founder’s intimate experience with eosinophilic gastroenteritis and frustration out of the lack of resources available led to the building of an organization rallied around change. APFED was born out of necessity.
The American Partnership for Eosinophilic Disorders (APFED) is a 501c3 nonprofit organization founded in December 2001 by a group of mothers of young children living with eosinophil-associated diseases. We are a patient advocacy group dedicated to improving the lives of those living with eosinophilic disorders.
Mission Statement:
To passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy.
Eosinophils are a type of white blood celland they play an important part of our immune system. Eosinophils help us fight off certain types of infections, such as parasites. Eosinophil-associated diseases are chronic and require long term management. The symptoms may be debilitating and often lead to missed time at school and work, and may greatly impact a patient’s quality of life.